Munafa Stock Market Course + Intraday & FNO calls 
Biomarin Pharmaceutical (BMRN) Technical (Analysis) Reports Biomarin Pharmaceutical ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Biomarin Pharmaceutical (BMRN)
Technical Analysis Report for USA stock BMRN Biomarin Pharmaceutical. Dated: 15 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock BMRN Biomarin Pharmaceutical then click here. or read Experts views on Biomarin Pharmaceutical or Forecast & share price targets of Biomarin Pharmaceutical
Biomarin Pharmaceutical Opened at 56.00 and Closed at: 55.27, which is -0.36% of previous session's close. It moved within a range of 54.99 and 56.05
The session was a Bearish session with an average volume of 1152700, which is -38.53% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
A Golden cross was found 3 days back on short term averages
A Dead cross was found 6 days back on long term averages
Support for tomorrow is 54.6 and resistance for tomorrow is 55.66
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 54.82, 54.38 resistance for tomorrow's hourly charts is 55.88, 56.5
10 Day SMA for Biomarin Pharmaceutical (BMRN) is 55.88 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Biomarin Pharmaceutical (BMRN) is 55.47 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Biomarin Pharmaceutical (BMRN) is 58.22 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 57.22 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Biomarin Pharmaceutical is 56.56 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Biomarin Pharmaceutical is at 55.47 and 200 DMA is at 56.56, while 50 DMA and 100 DMA are at 58.22 and 57.22 respectively
Biomarin Pharmaceutical (BMRN) moving average of 20 SMA is at 55.47 and 20 EMA is at 56.16
| Date | Closing Price | 20 SMA | 20 EMA |
| 15 Wed Apr | 55.27 | 55.47 | 56.16 |
| 14 Tue Apr | 55.47 | 55.58 | 56.25 |
| 13 Mon Apr | 54.88 | 55.73 | 56.33 |
| 10 Fri Apr | 54.53 | 55.94 | 56.48 |
| 09 Thu Apr | 56.30 | 56.23 | 56.68 |
| 08 Wed Apr | 57.20 | 56.46 | 56.72 |
Biomarin Pharmaceutical (BMRN) moving average of 50 SMA is at 58.22 and 50 EMA is at 57.1
| Date | Closing Price | 50 SMA | 50 EMA |
| 15 Wed Apr | 55.27 | 58.22 | 57.1 |
| 14 Tue Apr | 55.47 | 58.25 | 57.17 |
| 13 Mon Apr | 54.88 | 58.28 | 57.24 |
| 10 Fri Apr | 54.53 | 58.31 | 57.34 |
| 09 Thu Apr | 56.30 | 58.36 | 57.45 |
| 08 Wed Apr | 57.20 | 58.37 | 57.5 |
Biomarin Pharmaceutical (BMRN) moving average of 100 SMA is at 57.22 and 100 EMA is at 57.2
| Date | Closing Price | 100 SMA | 100 EMA |
| 15 Wed Apr | 55.27 | 57.22 | 57.2 |
| 14 Tue Apr | 55.47 | 57.21 | 57.24 |
| 13 Mon Apr | 54.88 | 57.2 | 57.28 |
| 10 Fri Apr | 54.53 | 57.19 | 57.33 |
| 09 Thu Apr | 56.30 | 57.2 | 57.39 |
| 08 Wed Apr | 57.20 | 57.19 | 57.41 |
Biomarin Pharmaceutical (BMRN) moving average of 200 SMA is at 56.56 and 200 EMA is at 58.07
| Date | Closing Price | 200 SMA | 200 EMA |
| 15 Wed Apr | 55.27 | 56.56 | 58.07 |
| 14 Tue Apr | 55.47 | 56.56 | 58.1 |
| 13 Mon Apr | 54.88 | 56.55 | 58.13 |
| 10 Fri Apr | 54.53 | 56.55 | 58.16 |
| 09 Thu Apr | 56.30 | 56.55 | 58.2 |
| 08 Wed Apr | 57.20 | 56.54 | 58.22 |
Biomarin Pharmaceutical has performed better than Novartis Ag in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Laboratory Corporation in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Iqvia Holdings has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Iqvia Holdings, about 7.13% more returns!
Humana Inc has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Humana Inc, about 17.43% more returns!
Biomarin Pharmaceutical has performed better than Supernus Pharmaceuticals in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Sol Gel has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Sol Gel, about 1.45% more returns!
Ovid Therapeutics has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Ovid Therapeutics, about 38.7% more returns!
Orthofix Medical has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Orthofix Medical, about 8.37% more returns!
Irhythm Technologies has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Irhythm Technologies, about 7.24% more returns!
Biomarin Pharmaceutical has performed better than Iradimed Corporation in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Incyte Corporation has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Incyte Corporation, about 4.45% more returns!
Biomarin Pharmaceutical has performed better than Galapagos Nv in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Ensign Group in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Cumberland Pharmaceuticals has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Cumberland Pharmaceuticals, about 7.7% more returns!
Aurinia Pharmaceuticals has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Aurinia Pharmaceuticals, about 12.31% more returns!
Biomarin Pharmaceutical has performed better than Arvinas Inc in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Alkermes Plc has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Alkermes Plc, about 21.53% more returns!
Biomarin Pharmaceutical Technical analysis of indicators
Price action analysis of Biomarin Pharmaceutical (BMRN) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Biomarin Pharmaceutical in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Biomarin Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Biomarin Pharmaceutical in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Biomarin Pharmaceutical is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 55.93 and Biomarin Pharmaceutical BMRN stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical BMRN stock. Volume based technical analysis of Biomarin Pharmaceutical BMRN stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock BMRN Biomarin Pharmaceutical These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And BMRN Experts View which covers a lot of information including buying and selling signals
BMRN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Biomarin Pharmaceutical or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Biomarin Pharmaceutical (BMRN) Technical (Analysis) Reports Biomarin Pharmaceutical ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
